Saturday 17 October 2026
Export ATHE’s income statement to Excel — free account
Alterity Therapeutics Limited - Sponsored ADR
ATHE Healthcare Biotechnology
Revenue growth for five consecutive years; insiders bought in the last twelve months.
2.62
0.10
−3.68%
Follow ATHE
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | 4 | 2 | 2 | 3 | 4 |
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | — | 2.15 | (19.56) | (7.37) | (4.93) | 3.78 |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | (3.25) | (52.26) | (16.67) | (13.35) | 4.19 |
Beneish M-Score |
— | — | — | — | — | 30.19 | (10.82) | (1.78) | (3.24) | (3.57) |
P/Operating CF |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
— | — | — | — | — | 0.86 | 0.26 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | 1.73 | 0.31 | 0.49 | 1.11 | 1.06 |
EV/FCF |
— | — | — | — | — | 1.73 | 0.31 | 0.49 | 1.10 | 1.06 |
Quick Ratio |
14.26 | 10.49 | 3.10 | 5.58 | 6.79 | 10.56 | 3.41 | 5.79 | 6.95 | 15.67 |
Current Ratio |
14.52 | 12.98 | 3.54 | 6.17 | 7.07 | 10.92 | 3.62 | 5.98 | 7.06 | 15.88 |
Net Debt/EBITDA |
1.32 | 1.67 | 0.55 | 0.91 | 1.99 | 1.89 | 0.71 | 1.17 | 1.97 | 3.31 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.21 | 0.01 | 0.25 | 0.15 | 0.11 |
Operating CF/Net income |
0.96 | 0.94 | 0.66 | 1.45 | 0.96 | 1.13 | 0.70 | 1.13 | 0.76 | 0.78 |
Capex/Depreciation |
0.00 | 0.00 | (0.04) | (0.07) | (1.65) | (0.14) | (0.15) | (0.24) | (2.86) | (1.30) |
| (56.26%) | (43.10%) | (102.77%) | (45.24%) | (38.44%) | (82.99%) | (108.60%) | (72.60%) | (42.26%) | (27.93%) | |
| (52.04%) | (37.10%) | (80.92%) | (38.41%) | (33.83%) | (72.06%) | (86.50%) | (61.37%) | (38.17%) | (26.06%) | |
ROIC |
(327.72%) | (135.49%) | (1,248.22%) | (154.05%) | (1,656.09%) | (396.76%) | 0.00% | (358.62%) | (574.31%) | (229.92%) |
Return on Tangible Assets |
(54.84%) | (28.69%) | (139.64%) | (60.75%) | (36.26%) | (50.27%) | (187.91%) | (74.37%) | (51.40%) | (31.84%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 346.52 | 160.15 | 348.40 | 345.85 | 351.17 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 272.62% | 7,221.62% | 256.60% | 201.33% | 180.67% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 153.97% | 2,464.43% | 85.15% | 130.48% | 135.48% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 41.83% | (8.63%) | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | (0.17%) | (0.23%) | (1.10%) | (39.46%) | (108.07%) |
Free Cash Flow Yield |
— | — | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.19 | 0.06 | 3.53 | 2.90 | 2.67 |
Operating CF per Share |
(0.87) | (0.70) | (1.36) | (3.33) | (2.23) | (4.58) | (4.25) | (9.72) | (5.44) | (4.97) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (0.02) | 0.00 | (0.01) | 0.00 | (0.05) | (0.02) |
Free Cash Flow per Share |
(0.87) | (0.70) | (1.36) | (3.33) | (2.25) | (4.58) | (4.25) | (9.73) | (5.49) | (4.99) |
Cash per Share |
1.44 | 2.01 | 1.36 | 2.62 | 6.30 | 7.43 | 4.14 | 10.03 | 13.27 | 18.54 |
Shareholders Equity per Share |
1.65 | 2.58 | 1.49 | 3.80 | 6.42 | 8.05 | 3.22 | 11.54 | 14.01 | 20.07 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.65 | 2.58 | 1.49 | 3.80 | 6.42 | 8.05 | 3.22 | 11.54 | 14.01 | 20.07 |
Free Cash Flow |
(15.29) | (7.42) | (8.27) | (13.49) | (9.02) | (12.96) | (6.34) | (9.99) | (4.89) | (4.44) |
Working Capital |
28.96 | 27.42 | 8.96 | 15.26 | 25.63 | 22.73 | 4.78 | 11.83 | 12.41 | 17.84 |
Capital Expenditures |
— | — | 0.00 | 0.00 | (0.06) | (0.01) | (0.01) | 0.00 | (0.05) | (0.02) |
Net Current Asset Value |
28.87 | 27.36 | 8.93 | 15.18 | 25.57 | 22.70 | 4.75 | 11.81 | 12.41 | 17.84 |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.02 | 0.01 |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
392.00 | 36.20 | 4.58 | 1.65 | 0.53 | 2.41 | 2.85 | 0.61 | 0.31 | 0.69 |
Cash ROIC |
(28.14%) | (15.15%) | (47.70%) | (51.94%) | (17.68%) | (29.60%) | (57.79%) | (45.10%) | (20.14%) | (12.93%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.08 | 0.05 | 1.23 | 1.09 | 0.82 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
3.89 | 2.60 | 4.24 | 4.63 | 3.31 | 1.62 | 1.75 | 2.95 | 2.37 | 2.89 |
Average Payables |
1.52 | 2.35 | 2.70 | 3.03 | 2.78 | 1.63 | 1.67 | 1.77 | 1.13 | 0.97 |
Average Assets |
30.52 | 21.21 | 15.50 | 24.20 | 27.55 | 15.87 | 10.45 | 14.38 | 16.79 | 21.82 |
Average Common Equity |
28.23 | 18.25 | 12.20 | 20.55 | 24.25 | 13.78 | 8.32 | 12.15 | 15.16 | 20.36 |
Columns are period end dates